Tarsus Pharmaceuticals management to meet with Oppenheimer
PremiumThe FlyTarsus Pharmaceuticals management to meet with Oppenheimer
2M ago
Tarsus Pharmaceuticals reports Q2 EPS (88c), consensus (92c)
Premium
The Fly
Tarsus Pharmaceuticals reports Q2 EPS (88c), consensus (92c)
3M ago
Tarsus Pharmaceuticals price target raised to $61 from $57 at H.C. Wainwright
Premium
The Fly
Tarsus Pharmaceuticals price target raised to $61 from $57 at H.C. Wainwright
6M ago
Tarsus Pharmaceuticals refinances existing debt with $200M financing
PremiumThe FlyTarsus Pharmaceuticals refinances existing debt with $200M financing
7M ago
Tarsus Pharmaceuticals introduces ‘Mite Party’ marketing campaign
Premium
The Fly
Tarsus Pharmaceuticals introduces ‘Mite Party’ marketing campaign
8M ago
Tarsus Pharmaceuticals 2.8M share Spot Secondary priced at $32.00
Premium
The Fly
Tarsus Pharmaceuticals 2.8M share Spot Secondary priced at $32.00
8M ago
Tarsus Pharmaceuticals price target raised to $59 from $55 at Oppenheimer
PremiumThe FlyTarsus Pharmaceuticals price target raised to $59 from $55 at Oppenheimer
9M ago
Tarsus Pharmaceuticals price target raised to $57 from $50 at H.C. Wainwright
Premium
The Fly
Tarsus Pharmaceuticals price target raised to $57 from $50 at H.C. Wainwright
9M ago
Tarsus Pharmaceuticals price target raised to $50 from $40 at Barclays
Premium
The Fly
Tarsus Pharmaceuticals price target raised to $50 from $40 at Barclays
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100